Adell Harriman & Carpenter’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-1,900
| Closed | -$247K | – | 181 |
|
2021
Q3 | $247K | Sell |
1,900
-2,600
| -58% | -$339K | 0.03% | 166 |
|
2021
Q2 | $799K | Sell |
4,500
-50
| -1% | -$8.88K | 0.08% | 114 |
|
2021
Q1 | $748K | Buy |
4,550
+950
| +26% | +$156K | 0.09% | 108 |
|
2020
Q4 | $594K | Buy |
3,600
+200
| +6% | +$33K | 0.08% | 108 |
|
2020
Q3 | $485K | Buy |
3,400
+1,050
| +45% | +$150K | 0.07% | 113 |
|
2020
Q2 | $259K | Sell |
2,350
-1,750
| -43% | -$193K | 0.04% | 119 |
|
2020
Q1 | $409K | Sell |
4,100
-1,250
| -23% | -$125K | 0.09% | 100 |
|
2019
Q4 | $799K | Sell |
5,350
-1,050
| -16% | -$157K | 0.13% | 95 |
|
2019
Q3 | $820K | Sell |
6,400
-4,175
| -39% | -$535K | 0.15% | 93 |
|
2019
Q2 | $1.51M | Sell |
10,575
-680
| -6% | -$96.9K | 0.28% | 79 |
|
2019
Q1 | $1.61M | Buy |
11,255
+2,020
| +22% | +$289K | 0.31% | 71 |
|
2018
Q4 | $1.14M | Sell |
9,235
-4,655
| -34% | -$577K | 0.25% | 81 |
|
2018
Q3 | $2.34M | Buy |
13,890
+100
| +0.7% | +$16.8K | 0.44% | 60 |
|
2018
Q2 | $2.38M | Buy |
13,790
+400
| +3% | +$68.9K | 0.47% | 57 |
|
2018
Q1 | $2.02M | Buy |
13,390
+1,475
| +12% | +$223K | 0.42% | 60 |
|
2017
Q4 | $1.6M | Sell |
11,915
-4,825
| -29% | -$650K | 0.34% | 74 |
|
2017
Q3 | $2.45M | Sell |
16,740
-200
| -1% | -$29.3K | 0.53% | 56 |
|
2017
Q2 | $2.63M | Buy |
16,940
+6,200
| +58% | +$964K | 0.6% | 55 |
|
2017
Q1 | $1.56M | Buy |
+10,740
| New | +$1.56M | 0.36% | 71 |
|
2015
Q4 | – | Sell |
-4,255
| Closed | -$565K | – | 141 |
|
2015
Q3 | $565K | Sell |
4,255
-2,785
| -40% | -$370K | 0.17% | 96 |
|
2015
Q2 | $1.24M | Hold |
7,040
| – | – | 0.32% | 73 |
|
2015
Q1 | $1.22M | Buy |
7,040
+1,990
| +39% | +$344K | 0.32% | 78 |
|
2014
Q4 | $827K | Buy |
+5,050
| New | +$827K | 0.23% | 86 |
|